coronavirus
cov
belong
subfamili
orthocoronavirina
famili
coronavirida
order
nidoviral
human
coronaviru
sarscov
caus
sever
acut
respiratori
syndrom
coronaviru
sar
outbreak
recent
sarsrel
cov
implic
etiolog
agent
respons
outbreak
wuhan
central
china
outbreak
estim
start
decemb
laboratori
confirm
case
death
februari
china
viru
spread
countri
travel
wuhan
typic
symptom
fever
malais
short
breath
sever
case
pneumonia
diseas
first
call
unidentifi
viral
pneumonia
quickli
identifi
etiolog
agent
term
viru
name
design
world
health
organ
newli
identifi
viru
sarsrel
viru
sarsrcov
share
genom
ident
sarscov
develop
molecular
detect
tool
base
viral
spike
gene
previou
studi
indic
qpcr
method
use
detect
oral
swab
bronchoalveolar
lavag
fluid
balf
addit
develop
igm
igg
detect
method
use
crossreact
nucleocapsid
protein
np
anoth
sarsrcov
ident
np
use
serolog
tool
demonstr
viral
antibodi
titr
increas
patient
infect
like
sarscov
induc
pneumonia
respiratori
tract
clinic
observ
therefor
presenc
viral
antigen
oral
swab
use
detect
standard
similarli
two
time
oral
swab
neg
interv
consid
viral
clearanc
patient
offici
launch
investig
wuhan
hospit
aim
investig
possibl
transmiss
rout
viru
human
sampl
includ
oral
swab
anal
swab
blood
sampl
collect
wuhan
pulmonari
hospit
consent
patient
approv
ethic
committe
design
hospit
emerg
infecti
diseas
two
investig
perform
first
investig
collect
sampl
patient
sever
condit
second
investig
collect
sampl
patient
yet
clinic
record
avail
show
patient
viral
nucleotid
detect
posit
patient
sampl
without
gender
age
prefer
unless
indic
swab
ml
fb
medium
ad
tube
supernat
collect
rpm
vortex
min
stand
supernat
swab
ad
lysi
buffer
rna
extract
serum
separ
centrifug
g
min
within
h
collect
follow
min
inactiv
store
use
whenev
commerci
kit
use
manufactur
instruct
follow
without
modif
rna
extract
sampl
high
pure
viral
rna
kit
roch
rna
elut
elut
buffer
use
templat
qpcr
detect
method
base
gene
found
previou
studi
brief
rna
extract
use
qpcr
ii
one
step
qrtpcr
green
kit
vazym
biotech
co
ltd
qpcr
reaction
mix
contain
one
step
sybr
green
mix
one
step
sybr
green
enzym
mix
rox
refer
dye
primer
templat
rna
amplif
perform
follow
min
follow
cycl
consist
default
melt
curv
step
abi
machin
inhous
antisarsrcov
igg
igm
elisa
kit
develop
use
sarsrcov
np
antigen
share
amino
acid
ident
sarsrcov
report
previous
igg
test
maxisorp
nuncimmuno
well
elisa
plate
coat
ngwell
overnight
recombin
np
human
sera
use
dilut
h
antihuman
igghrp
conjug
monoclon
antibodi
kyab
biotech
co
ltd
wuhan
china
use
dilut
od
valu
calcul
igm
test
maxisorp
nuncimmuno
wellelisa
plate
coat
ngwell
overnight
antihuman
igm
chain
human
sera
use
dilut
min
follow
nphrp
conjug
kyab
biotech
co
ltd
wuhan
china
dilut
od
valu
calcul
first
investig
aim
test
whether
viral
posit
found
anal
swab
blood
well
oral
swab
conduct
molecular
investig
patient
wuhan
pulmonari
hospit
detect
oral
swab
posit
upon
admiss
collect
blood
oral
swab
anal
swab
qpcr
test
use
previous
establish
method
found
patient
still
carri
viru
follow
day
medic
treatment
patient
oral
swab
posit
anal
swab
posit
blood
posit
serum
posit
two
patient
posit
oral
swab
anal
swab
yet
none
blood
posit
also
swab
posit
surprisingli
serum
posit
also
whole
serum
posit
tabl
summari
viral
nucleotid
found
anal
swab
blood
even
detect
oral
swab
note
although
swab
may
neg
patient
might
still
virem
anoth
investig
find
dynam
chang
viral
presenc
two
consecut
studi
oral
anal
swab
anoth
group
patient
target
patient
receiv
around
day
medic
treatment
upon
admiss
test
viral
antibodi
viral
nucleotid
level
previous
establish
method
show
igm
igg
titr
rel
low
undetect
day
day
first
sampl
day
increas
viral
antibodi
seen
nearli
patient
normal
consid
transit
earlier
later
period
infect
figur
supplementari
tabl
igm
posit
rate
increas
wherea
igg
posit
rate
increas
contrast
rel
low
detect
posit
rate
molecular
test
molecular
detect
found
oral
swab
posit
anal
swab
peopl
day
day
abl
find
oral
swab
posit
contrast
found
anal
swab
posit
count
swab
posit
togeth
found
posit
came
oral
swab
day
howev
trend
appear
chang
day
found
anal
swab
posit
oral
swab
posit
anoth
observ
reoccurr
viru
patient
detect
neg
day
note
viral
posit
anal
swab
tabl
data
suggest
shift
oral
posit
earli
period
indic
antibodi
titr
anal
posit
later
period
might
happen
within
month
diseas
outbreak
rapidli
develop
molecular
serolog
detect
tool
first
molecular
serolog
studi
viru
initi
identif
patient
diagnos
unidentifi
viral
pneumonia
detect
viru
oral
swab
anal
swab
blood
thu
infect
patient
potenti
shed
pathogen
respiratori
bodi
fluid
rout
addit
success
appli
serolog
test
larg
popul
show
could
greatli
improv
detect
posit
rate
show
current
strategi
detect
viral
rna
oral
swab
use
diagnosi
perfect
viru
may
present
anal
swab
blood
patient
oral
swab
detect
neg
sarscov
merscov
infect
patient
intestin
infect
observ
later
stage
infect
howev
patient
infect
may
harbour
viru
intestin
earli
late
stage
diseas
also
worth
note
none
patient
viremia
blood
posit
swab
patient
would
like
consid
neg
routin
surveil
thu
pose
threat
peopl
contrast
found
viral
antibodi
near
patient
indic
serolog
consid
epidemiolog
possibl
shift
oral
posit
earli
infect
anal
swab
posit
late
infect
observ
observ
impli
discharg
patient
pure
base
oral
swab
neg
may
still
shed
viru
rout
strongli
suggest
use
viral
igm
igg
serolog
test
confirm
infect
consid
unreli
result
oral
swab
detect
summari
provid
cautionari
warn
may
transmit
multipl
rout
molecular
serolog
test
need
definit
confirm
viru
carrier
